Zila shows off ViziLite at Yankee Dental

Feb. 4, 2002
The ViziLite device is used in conjunction with a conventional visual oral mucosal examination to improve the identification, evaluation and monitoring of oral mucosal abnormalities in those at increased risk for oral cancer.

Gregory Stoute, DMD, MPH, Chief of Dentistry, Harvard University, University Health Services and President, National Dental Association, observed, "This early detection technology should benefit a large population, and may be of particular value to vulnerable groups, such as African-Americans whose average rate of oral cancer survival is 19 percent lower than that of the general population (35 percent vs. 54 percent, according to the Government's 2000 SEER data)."

Cold, blustery and snowy weather conditions at the 2002 Winter Games are great for the events, but may sufficiently increase one's susceptibility to cold sores and sensitive teeth, reports the Academy of General Dentistry, an organization of general dentists.